-+ 0.00%
-+ 0.00%
-+ 0.00%

Ascendiant Capital Maintains Buy on Synergy CHC, Raises Price Target to $5.5

Benzinga·04/14/2026 11:28:52
Listen to the news
Ascendiant Capital analyst Edward Woo maintains Synergy CHC (NASDAQ:SNYR) with a Buy and raises the price target from $5 to $5.5.